BzATP triethylammonium salt

BzATP triethylammonium salt acts as a P2X receptor agonist with pEC50s of 8.74, 5.26, 7.10, 7.50, 6.19, 6.31, 5.33 for P2X1, P2X2, P2X3, P2X2/3, P2X4 and P2X7, respectively, also is potent at P2X7 receptors with EC50s of 3.6 μM and 285 μM for rat P2X7 and mouse P2X7, respectively.

BzATP triethylammonium salt Chemical Structure

BzATP triethylammonium salt Chemical Structure

CAS No. 112898-15-4

Purity & Quality Control

Batch: E112801 Water]100 mg/mL]false]DMSO]50 mg/mL]false]Ethanol]Insoluble]false Purity: 99.44%
99.44

BzATP triethylammonium salt Related Products

Biological Activity

Description BzATP triethylammonium salt acts as a P2X receptor agonist with pEC50s of 8.74, 5.26, 7.10, 7.50, 6.19, 6.31, 5.33 for P2X1, P2X2, P2X3, P2X2/3, P2X4 and P2X7, respectively, also is potent at P2X7 receptors with EC50s of 3.6 μM and 285 μM for rat P2X7 and mouse P2X7, respectively.
Targets
P2X1 [1]
(in fluo-3 Ca2+ influx assay)
P2X3 [1]
(in fluo-3 Ca2+ influx assay)
P2X4 [1]
(in fluo-3 Ca2+ influx assay)
P2X2/3 [1]
(in fluo-3 Ca2+ influx assay)
P2X7 [1]
(in fluo-3 Ca2+ influx assay)
Click to View More Targets
8.74(pEC50) 7.1(pEC50) 6.31(pEC50) 6.19(pEC50) 5.33(pEC50)

Chemical Information & Solubility

Molecular Weight 816.58 Formula

C24H24N5O15P3.C6H15N

CAS No. 112898-15-4 SDF --
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

Water : 100 mg/mL

DMSO : 50 mg/mL ( (61.23 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy BzATP triethylammonium salt | BzATP triethylammonium salt supplier | purchase BzATP triethylammonium salt | BzATP triethylammonium salt cost | BzATP triethylammonium salt manufacturer | order BzATP triethylammonium salt | BzATP triethylammonium salt distributor